Insider Transactions in Q4 2025 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2025
|
Stephen F. Betz Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+13.26%
|
$18,000
$1.91 P/Share
|
|
Dec 18
2025
|
Richard Scott Struthers President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,742
+5.93%
|
$536,904
$12.29 P/Share
|
|
Dec 01
2025
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.96%
|
$225,000
$45.02 P/Share
|
|
Dec 01
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.51%
|
$80,000
$16.89 P/Share
|
|
Nov 03
2025
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.51%
|
$210,000
$42.96 P/Share
|
|
Nov 03
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.56%
|
$80,000
$16.89 P/Share
|
|
Oct 01
2025
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.02%
|
$205,000
$41.81 P/Share
|
|
Oct 01
2025
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.56%
|
$80,000
$16.89 P/Share
|